Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site

References

• Balazs, AB, Chen J, Hong CM, Rao DS, Yang L, Baltimore D. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature. 2011;481(7379):81–84. doi:10.1038/nature10660.
   PubMed Web of Science ®Google Scholar
• Xue, C., Tian X, Li X, Zhou Z, Su X, Zhou R. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon. Virus Res. 2014;183:67–74. doi:10.1016/j.virusres.2014.01.027.
   PubMed Web of Science ®Google Scholar
• Gu, L., Li ZC, Krendelchtchikov A, Krendelchtchikova V, Wu H, Matthews QL. Using multivalent adenoviral vectors for HIV vaccination. PLoS One. 2013;8(3):e60347. doi:10.1371/journal.pone.0060347.
   PubMed Web of Science ®Google Scholar
• Nayerossadat N, Maedeh T, Ali PA. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res. 2012;1:27. doi:10.4103/2277-9175.98152.
   PubMedGoogle Scholar
• Minor PD. Live attenuated vaccines: historical successes and current challenges. Virology. 2015;479-480:379–392. doi:10.1016/j.virol.2015.03.032.
   PubMed Web of Science ®Google Scholar
• Isakova-Sivak I, Tretiak T, Rudenko L. Cold-adapted influenza viruses as a promising platform for viral-vector vaccines. Expert Rev Vaccines. 2016; 15(10): 1241–1243.
   PubMed Web of Science ®Google Scholar
• Hoft, DF, Lottenbach KR, Blazevic A, Turan A, Blevins TP, Pacatte TP, Yu Y, Mitchell MC, Hoft SG, Belshe RB. Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults. Clin Vaccine Immunol. 2017;24(1). doi:10.1128/CVI.00414-16.
   Web of Science ®Google Scholar
• Jin H, Subbarao K. Live attenuated influenza vaccine. Curr Top Microbiol Immunol. 2015;386:181–204. doi:10.1007/82_2014_410.
   PubMed Web of Science ®Google Scholar
• Laurie, KL, Guarnaccia TA, Carolan LA, Yan AWC, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, et al. Interval between infections and viral hierarchy are determinants of viral interference following influenza virus infection in a Ferret model. J Infect Dis. 2015;212(11):1701–1710. doi:10.1093/infdis/jiv260.
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S. Role of NK cells in influenza infection. Curr Top Microbiol Immunol. 2015;386:109–120. doi:10.1007/82_2014_403.
   PubMed Web of Science ®Google Scholar
• Mohn KGI, Zhou F, Brokstad KA, Sridhar S, Cox RJ. Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination. J Infect Dis. 2017;215(10):1527–1535. doi:10.1128/CVI.00037-16.
   PubMed Web of Science ®Google Scholar
• van Riet E, Ainai A, Suzuki T, Hasegawa H. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. Vaccine. 2012;30(40):5893–5900. doi:10.1016/j.vaccine.2012.04.109.
   PubMed Web of Science ®Google Scholar
• Li J, Arevalo MT, Zeng M. Engineering influenza viral vectors. Bioengineered. 2013;4(1):9–14. doi:10.4161/bioe.21950.
   PubMed Web of Science ®Google Scholar
• Isakova-Sivak I, Chen LM, Matsuoka Y, Voeten JT, Kiseleva I, Heldens JG, den Bosch H, Klimov A, Rudenko L, Cox N.J, et al. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: a/Leningrad/134/17/57 (H2N2). Virology. 2011;412(2):297–305. doi:10.1016/j.virol.2011.01.004.
   PubMed Web of Science ®Google Scholar
• Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin Microbiol Rev. 2017;30(1):277–319. doi:10.1128/CMR.00010-16.
   PubMed Web of Science ®Google Scholar
• Neuzil KM. Progress toward a respiratory syncytial virus vaccine. Clin Vaccine Immunol. 2016;23(3):186–188. doi:10.1128/CVI.00037-16.
   PubMed Web of Science ®Google Scholar
• Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, Garcia-Sastre A, Palese P. Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A. 2000;97(8):4309–4314. doi:10.1073/pnas.070525997.
   PubMed Web of Science ®Google Scholar
• Steel J, Lowen AC, Pena L, Angel M, Solorzano A, Albrecht R, Perez DR, Garcia-Sastre A, Palese P. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol. 2009;83(4):1742–1753. doi:10.1128/JVI.01920-08.
   PubMed Web of Science ®Google Scholar
• Maassab HF, Kendal AP, Abrams GD, Monto AS. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis. 1982;146(6):780–790.
   PubMed Web of Science ®Google Scholar
• Wareing MD, Watson JM, Brooks MJ, Tannock GA. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice. J Med Virol. 2001;65(1):171–177.
   PubMed Web of Science ®Google Scholar
• Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, Subba AX, Shi Z, Zaki SR, Blau DM, Garcia-Sastre A, et al. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets. Vaccine. 2010;28(50):8015–8025. doi:10.1016/j.vaccine.2010.08.106.
   PubMed Web of Science ®Google Scholar
• Ferko B, Stasakova J, Sereinig S, Romanova J, Katinger D, Niebler B, Katinger H, Egorov A. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice. J Virol. 2001;75(19):8899–8908. doi:10.1128/JVI.75.19.8899-8908.2001.
   PubMed Web of Science ®Google Scholar
• Kulkarni AB, Collins PL, Bacik I, Yewdell JW, Bennink JR, Crowe JE, Jr. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J Virol. 1995;69(2):1261–1264.
   PubMed Web of Science ®Google Scholar
• Lee S, Miller SA, Wright DW, Rock MT, Crowe JE. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection. J Virol. 2007;81(5):2349–2358. doi:10.1128/JVI.01910-06.
   PubMed Web of Science ®Google Scholar
• McDermott DS, Knudson CJ, Varga SM. Determining the breadth of the respiratory syncytial virus-specific T cell response. J Virol. 2014;88(6):3135–3143. doi:10.1128/JVI.02139-13.
   PubMed Web of Science ®Google Scholar
• Ruckwardt TJ, Luongo C, Malloy AM, Liu J, Chen M, Collins PL, Graham BS. Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. J Immunol. 2010;185(8):4673–4680. doi:10.4049/jimmunol.1001606.
   PubMed Web of Science ®Google Scholar
• Kim, JH, Lee SR, Li LH, Park HJ, Park JH, Lee KY, Kim MK, Shin BA, Choi SY. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One. 2011;6(4):e18556. doi:10.1371/journal.pone.0018556.
   PubMed Web of Science ®Google Scholar
• Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y. Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A. 2003;100(4):2002–2007. doi:10.1073/pnas.0437772100.
   PubMed Web of Science ®Google Scholar
• Durward M, Harms J, Splitter G. Antigen specific killing assay using CFSE labeled target cells. J Vis Exp. 2010;(45). PubMed: J Vis Exp. 2010 Nov 9;(45). pii: 2250. doi: 10.3791/2250.
   PubMedGoogle Scholar